Clinical Trials on Hepcidin, Saliva

Total 833 results

National Cancer Institute (NCI)

Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
Rennes University Hospital

Completed

Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages (MacFibOsis)

History of Exposure to Silica or Asbestosis | Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases

France
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
Medical University of South Carolina
Invado Pharmaceuticals LLC

Completed

NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Xerostomia

United States
GlaxoSmithKline

Withdrawn

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)

Autoimmune Diseases

United Kingdom
Beth Israel Deaconess Medical Center

Completed

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Sialorrhea

United States
Alcon Research

Completed

Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention

Sjogren's Syndrome

Canada
China Medical University Hospital

Unknown

The Related Factors With Resilience in Caregivers Whose Child With Leukemia

Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. | Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission. | Condition 3. Caregiver Can or Taiwanese Language Communicator.

Taiwan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer

Recurrent Head and Neck Carcinoma | Recurrent Skin Carcinoma | Recurrent Salivary Gland Carcinoma | Skin Squamous Cell Carcinoma

United States
Hadassah Medical Organization

Unknown

Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?

Head and Neck Cancer | Weight Loss | Xerostomia | Oral Mucositis

Israel
Saglik Bilimleri Universitesi

Not yet recruiting

The Effect of Mindfulness-based Stress Reduction Programme Given to Infertile Women

Dependent Variables of the Study: Anxiety, Depression, Stress and Salivary Cortisol Levels | Independent Variables of the Study: Women's Socio-demographic Characteristics, Mindfulness-based Stress Reduction Program

Turkey
Sinovac Biotech Co., Ltd

Active, not recruiting

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Mumps | Influenza

China
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
GlaxoSmithKline
Quintiles, Inc.

Completed

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Autoimmune Diseases

United Kingdom
Mahidol University

Completed

Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service

Bradycardia | Hypersalivation | Prevention of Drooling | Reversal of Muscle Relaxants

Thailand
National Cancer Institute (NCI)

Terminated

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Ovarian Endometrioid Adenocarcinoma | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer and other conditions

United States
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

HER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid Tumor

China, Australia, United States
UNC Lineberger Comprehensive Cancer Center

Completed

Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx

Head and Neck Cancer | Oropharynx Cancer | Xerostomia Due to Radiotherapy

United States
University of Rochester
Bausch & Lomb Incorporated

Completed

Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

Sjogren's Disease

United States
National Cancer Institute (NCI)

Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions

United States
Stanford University
National Cancer Institute (NCI); Agennix

Terminated

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditions

United States
Stanford University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma

Xerostomia

United States
Second Affiliated Hospital of Soochow University

Active, not recruiting

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Salivation in Parkinson's Disease

China
University Hospital, Brest

Completed

Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study (PREDELFI)

Xerostomia | Sicca Syndrome

France
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Head and Neck Cancer | Dysphagia | Mucositis | Xerostomia

United States
Ege University

Completed

Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients

Xerostomia | Sjögren's Syndrome

Turkey
Hacettepe University

Completed

Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth

Sjogren's Syndrome | Xerostomia

Turkey
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Tongue Cancer | Salivary Gland Squamous Cell Carcinoma | Stage IV Non-small Cell Lung Cancer | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IV Squamous Cell Carcinoma of the Nasopharynx | Metastatic Squamous... and other conditions

United States
University Medical Center Groningen
AstraZeneca

Recruiting

Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome (ANISE-II)

Sjogren's Syndrome

Netherlands
Peking Union Medical College Hospital
Eli Lilly and Company

Recruiting

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Sjogren's Syndrome

China
Janssen Research & Development, LLC

Completed

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Sjogren's Syndrome

United States, Germany, Netherlands, Japan, Taiwan, Italy, France, Spain, Poland, Portugal
Sun Yat-sen University

Completed

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Nasopharyngeal Carcinoma | Radiation-induced Xerostomia

China
Arthritis & Rheumatism Associates, P.C.
Bristol-Myers Squibb

Active, not recruiting

Sjogrens Syndrome Measured by Ultrasound

Sjogren's Syndrome

United States
Resolve Therapeutics
Newcastle-upon-Tyne Hospitals NHS Trust; University Hospital Birmingham

Completed

A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome (RSLV-132)

Sjogren's Syndrome

United Kingdom
Gilead Sciences
Ono Pharmaceutical Co. Ltd; Galapagos NV

Completed

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

Sjogren's Syndrome

United States, Spain, United Kingdom, Poland
University Hospital, Brest

Completed

Ultrasound Elastography of Salivary Glands (ELSA)

sjögren Disease

France
Derk Jan Jager
University Medical Center Groningen; UMC Utrecht; Fonds NutsOhra; Isala; Tandartspraktijk... and other collaborators

Completed

Implantology and Sjögren's Syndrome

Sjogren's Syndrome

Netherlands
University of Rochester

Completed

Multi-Colored Placido Disk Viability

Healthy | Dry Eye | Sjogren's Disease

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence

Completed

Anti-CD20 Antibody Therapy for Sjogren's Syndrome

Sjogren's Syndrome

United States
National Institute of Dental and Craniofacial Research...

Terminated

Pilot Study of Raptiva to Treat Sjogren's Syndrome

Sjogren's Syndrome

United States
University of Tromso

Completed

Oral Health Literacy Tailored Communication

Periodontal Diseases | Streptococcal Infections | Dental Plaque | Sialorrhea | Dental Calculus | Lactobacillus Infection

Norway
University of Waterloo
Sjogren's Society of Canada

Completed

Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome (TOYOTA)

Sjogren's Syndrome

Canada
University of Roma La Sapienza

Unknown

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction (SPEEDCARS)

Sjogren Syndrome

Italy
Alcon Research

Completed

Evaluation of FID 114657 in Sjogren's Syndrome Subjects

Sjogren's Syndrome
University Medical Center Groningen
Hoffmann-La Roche

Completed

Rituximab Treatment in Sjogren's Syndrome

Sjogren's Syndrome

Netherlands
National Institute of Dental and Craniofacial Research...

Completed

Etanercept Therapy for Sjogren's Syndrome

Sjogren's Syndrome

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Ro60 Expression in Macrophages in Sjogren's Disease (RoMioSS)

Sjogren's Syndrome

France
University Hospital, Brest

Recruiting

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome (BRAISES-DiaPSS)

Sjogren's Syndrome

France
National Institute of Dental and Craniofacial Research...

Recruiting

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome

Sjogren's Syndrome

United States

Clinical Trials on Hepcidin, Saliva

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations